ChemGenex Pharmaceuticals Limited (ADR) (CXSP)
$16.00
0.00 (0%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $16.00 |
| Daily Range | $14.00 - $16.00 |
| 52-Week Range | $10.01 - $24.50 |
| Market Cap | $101.35M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 0 |
| Average Daily Volume | 0 |
How do you think CXSP will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CXSP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
Related News and Articles
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- Small and Volatile, but Not for Long – The Motley Fool
- Saved by Emerging Markets. Sort Of. – The Motley Fool
- 2 Stocks Hitting Low Notes – The Motley Fool
- Small Market, Small Acquisition, Still a Good Move – The Motley Fool
- Swine Flu Doesn't Need to Save Novartis – The Motley Fool
- Not 50% Growth, but We'll Take It – The Motley Fool


RSS Headlines
Fool UK